Ampersand Capital Acquires Willow Laboratories

Willow Laboratories, based in Lynn, Mass., has been acquired by Ampersand Capital Partners. Willow is a clinical and forensic toxicology laboratory that provides urine, hair, and saliva testing services to a wide range of healthcare providers, including treatment centers. Ampersand is a Boston-based, middle market private equity firm. Terms of the deal were not disclosed.

PE HUB Community

Join the 12515 members of PE HUB to make connections, share your opinion, and follow your favorite authors.

Join the Community

Look Who’s Tweeting

PE HUB News Briefs

RSS Feed Widget

VCJ Headlines (subscribers only)

RSS Feed Widget

Buyouts Headlines (subscribers only)

RSS Feed Widget